Co-operators Financial Services Limited to Acquire Smart Employee Benefits Inc.

Written by Customer Service on January 3, 2023. Posted in Mergers And Acquisitions.

TORONTO, Jan. 03, 2023 (GLOBE NEWSWIRE) — Co-operators Financial Services Limited (“Co-operators”), a wholly owned subsidiary of The Co-operators Group Limited, and Smart Employee Benefits Inc. (TSXV: SEB) (OTCQB: SEBFF) (“SEB”) announced today that they have entered into an arrangement agreement (the “Arrangement Agreement”) dated January 3, 2023 pursuant to which Co-operators will, indirectly through its wholly-owned subsidiary, acquire all of the issued and outstanding common shares of SEB (“SEB Shares”) by way of a statutory plan of arrangement (“Plan of Arrangement”) under the Business Corporations Act (Ontario) (the “Transaction”). Pursuant to the Arrangement Agreement, Co-operators will acquire all of the issued and outstanding SEB Shares, other than those already owned by Co-operators, at a purchase price of $0.30 in cash...

Travere Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 3, 2023. Posted in Public Companies.

SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference, on Thursday, January 12, 2023, at 11:15 a.m. PT. A live webcast of the presentation will be accessible on the company’s website, ir.travere.com, under the “Events & Presentations” section, and an archived replay will be accessible for up to 30 days. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global...

Meritage Homes Fourth Quarter 2022 Earnings Conference Call and Webcast Scheduled for February 2, 2023

Written by Customer Service on January 3, 2023. Posted in Public Companies.

SCOTTSDALE, Ariz., Jan. 03, 2023 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, plans to release the Company’s fourth quarter 2022 results on Wednesday, February 1, 2023 after the market closes. Management will host a conference call to discuss the results at 8:00 a.m. Mountain Standard Time (10:00 a.m. Eastern Standard Time) on Thursday, February 2, 2023. The call will be webcast with an accompanying slideshow, both available on the “Investor Relations” page of the Company’s website at https://investors.meritagehomes.com. A live webcast of the conference call will be available online at https://investors.meritagehomes.com. Telephone participants will be able to join by dialing in to 1-877-407-6951 US toll free or 1-412-902-0046 on the day of the call. A replay of...

ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 3, 2023. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 11:15 a.m. PT. A live webcast of the company presentation will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event. About ORIC Pharmaceuticals, Inc. ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical...

Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference

Written by Customer Service on January 3, 2023. Posted in Public Companies.

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10th at 4:30 p.m. PST in San Francisco, CA. A live webcast of the company presentation will be available on the investor section of the company website at investors.generationbio.com. About Generation BioGeneration Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral genetic medicine platform incorporates a novel DNA construct called closed-ended DNA, or ceDNA; a unique cell-targeted lipid nanoparticle delivery system, or ctLNP; and a highly...

Roman Loosen Joins Fluence as Senior Vice President, Chief Business Operations and Transformation Officer to Oversee Operational Excellence

Written by Customer Service on January 3, 2023. Posted in Public Companies.

ARLINGTON, Va., Jan. 03, 2023 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a leading global provider of energy storage products and services, and cloud-based software for renewables and storage, today announced that effective January 1, 2023, Roman Loosen has joined Fluence as Senior Vice President and Chief Business Operations and Transformation Officer to lead the strategic transformation and accelerated growth of Fluence’s business operations. Mr. Loosen joins Fluence from Siemens, where he spent more than 20 years as a change agent, implementing proven business transformation strategies in various roles and countries across the Siemens organization. “Roman’s demonstrated success as a business transformation and change management expert will help lead Fluence into our next chapter of profitable growth,”...

Great Elm Group Sells Durable Medical Equipment Business for $80 Million

Written by Customer Service on January 3, 2023. Posted in Public Companies.

The Sale of its DME Business Allows Great Elm to Focus Primarily on Investment Management with Additional Cash on its Balance Sheet Available to Fund Strategic Growth Initiatives WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — Great Elm Group, Inc. (“we,” “us,” “our,” the “Company,” “GEG,” or “Great Elm”), (NASDAQ: GEG) today announced the closing of the sale of its majority interest in the Company’s Durable Medical Equipment (DME) business, Great Elm Healthcare, LLC, to QHM Holdings, Inc., a wholly-owned subsidiary of Quipt Home Medical Corp. (“Quipt”), (NASDAQ: QIPT; TSXV: QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care. Transaction Terms and Highlights Total consideration of $80 million includes approximately $73 million of cash, $5 million of assumed indebtedness and...

Quipt Acquires $60 Million in Revenues and $13 Million Adjusted EBITDA with Strategic Acquisition of Great Elm Healthcare, LLC

Written by Customer Service on January 3, 2023. Posted in Public Companies.

Quipt Reaches $220 Million in Annualized Revenues and $49 Million of Anticipated Annualized Adjusted EBITDA CINCINNATI, Jan. 03, 2023 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has acquired Great Elm Healthcare, LLC (“Great Elm”), a division of Great Elm Group, Inc. (NASDAQ:GEG) (the “Acquisition”), with an effective date of December 31, 2022. Great Elm operates a complete line of respiratory related durable medical equipment service locations across eight states in the Midwest, Southwest and Pacific Northwest. Based on an independent quality of earnings report, Great Elm had unaudited revenues for the 12 months ended August 31, 2022 of $60 million ‎with...

EverQuote to Participate at the 25th Annual Needham Growth Conference

Written by Customer Service on January 3, 2023. Posted in Public Companies.

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced that management will participate and host one-on-one investor meetings at the following investor conference: 25th Annual Needham Growth ConferenceDate: Tuesday, January 10, 2023Fireside Chat Time: 10:15 a.m. ETLocation: New York, NY Conference fireside chats will be available via live audio webcast and archived replay on EverQuote’s investor relations website at http://investors.everquote.com. Safe Harbor StatementAny statements in this press release about future expectations, plans and prospects for EverQuote, Inc. (“EverQuote” or the “Company”), including statements about future results of operations or the future financial position of the Company, including financial targets, business strategy,...

SUN COMMUNITIES ADOPTS CLIMATE CHANGE GOALS

Written by Customer Service on January 3, 2023. Posted in Public Companies.

Targets 2035 for Carbon Neutrality, 2045 for Net Zero Emissions Southfield, Michigan, Jan. 03, 2023 (GLOBE NEWSWIRE) — Sun Communities, Inc. (“Sun” or the “Company”) (NYSE: SUI), a real estate investment trust (“REIT”) that owns and operates, or has an interest in, manufactured housing (“MH”) and recreational vehicle (“RV”) communities, and marinas (collectively, the “properties”), today announced it has adopted goals to achieve Carbon Neutrality by 2035 and Net Zero Emissions by 2045. This commitment is part of a concerted effort by Sun to significantly reduce greenhouse gas emissions and ultimately reach net-zero emissions to limit global warming and prevent the adverse effects of climate change. The scope of Sun’s commitment will be seen across all its properties, as it works toward achieving its climate change goals through...

Day: January 3, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice